杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/10/07 | 2,164 | 2,174 | 2,155 | 2,160 | -4 | -0.2% | 99,100 |
2020/10/06 | 2,181 | 2,187 | 2,147 | 2,164 | -7 | -0.3% | 122,000 |
2020/10/05 | 2,143 | 2,194 | 2,143 | 2,171 | +46 | +2.2% | 114,700 |
2020/10/02 | 2,144 | 2,156 | 2,101 | 2,125 | - | - | 206,600 |
2020/10/01 | 0 | 0 | 0 | 0 | - | - | 0 |
2020/09/30 | 2,139 | 2,171 | 2,131 | 2,132 | -15 | -0.7% | 164,700 |
2020/09/29 | 2,126 | 2,160 | 2,108 | 2,147 | -43 | -2% | 125,000 |
2020/09/28 | 2,164 | 2,195 | 2,146 | 2,190 | +55 | +2.6% | 252,200 |
2020/09/25 | 2,157 | 2,180 | 2,131 | 2,135 | -41 | -1.9% | 216,200 |
2020/09/24 | 2,202 | 2,202 | 2,172 | 2,176 | -25 | -1.1% | 154,400 |
2020/09/23 | 2,210 | 2,218 | 2,189 | 2,201 | -24 | -1.1% | 166,000 |
2020/09/18 | 2,214 | 2,234 | 2,198 | 2,225 | +14 | +0.6% | 204,300 |
2020/09/17 | 2,182 | 2,211 | 2,168 | 2,211 | +24 | +1.1% | 110,400 |
2020/09/16 | 2,180 | 2,205 | 2,167 | 2,187 | +15 | +0.7% | 172,800 |
2020/09/15 | 2,164 | 2,174 | 2,151 | 2,172 | +10 | +0.5% | 108,400 |
2020/09/14 | 2,162 | 2,168 | 2,147 | 2,162 | +8 | +0.4% | 110,600 |
2020/09/11 | 2,143 | 2,159 | 2,131 | 2,154 | +31 | +1.5% | 154,700 |
2020/09/10 | 2,110 | 2,128 | 2,102 | 2,123 | +19 | +0.9% | 155,900 |
2020/09/09 | 2,062 | 2,108 | 2,060 | 2,104 | -4 | -0.2% | 205,600 |
2020/09/08 | 2,067 | 2,108 | 2,063 | 2,108 | +47 | +2.3% | 173,300 |
2020/09/07 | 2,036 | 2,076 | 2,034 | 2,061 | +24 | +1.2% | 130,600 |
2020/09/04 | 2,019 | 2,046 | 2,007 | 2,037 | +1 | ±0% | 159,100 |
2020/09/03 | 2,046 | 2,062 | 2,029 | 2,036 | +11 | +0.5% | 201,600 |
2020/09/02 | 1,996 | 2,034 | 1,996 | 2,025 | +13 | +0.6% | 160,500 |
2020/09/01 | 2,007 | 2,020 | 1,989 | 2,012 | +5 | +0.2% | 140,000 |
2020/08/31 | 1,990 | 2,034 | 1,988 | 2,007 | +28 | +1.4% | 290,500 |
2020/08/28 | 1,990 | 2,029 | 1,966 | 1,979 | -5 | -0.3% | 231,300 |
2020/08/27 | 1,990 | 1,996 | 1,979 | 1,984 | -15 | -0.8% | 128,800 |
2020/08/26 | 1,981 | 2,006 | 1,971 | 1,999 | -8 | -0.4% | 132,300 |
2020/08/25 | 2,024 | 2,024 | 1,999 | 2,007 | -1 | ±0% | 132,900 |
2020/08/24 | 2,015 | 2,020 | 1,995 | 2,008 | -7 | -0.3% | 109,500 |
2020/08/21 | 2,026 | 2,032 | 2,007 | 2,015 | ±0 | ±0% | 109,700 |
2020/08/20 | 2,007 | 2,025 | 2,004 | 2,015 | +3 | +0.1% | 142,100 |
2020/08/19 | 2,001 | 2,020 | 2,000 | 2,012 | +8 | +0.4% | 134,300 |
2020/08/18 | 1,998 | 2,013 | 1,991 | 2,004 | -6 | -0.3% | 118,900 |
2020/08/17 | 2,032 | 2,033 | 2,010 | 2,010 | -20 | -1% | 82,900 |
2020/08/14 | 2,038 | 2,050 | 2,008 | 2,030 | -25 | -1.2% | 163,500 |
2020/08/13 | 2,075 | 2,075 | 2,044 | 2,055 | +17 | +0.8% | 168,400 |
2020/08/12 | 2,001 | 2,043 | 1,999 | 2,038 | +41 | +2.1% | 229,200 |
2020/08/11 | 1,972 | 2,016 | 1,956 | 1,997 | +48 | +2.5% | 197,800 |
2020/08/07 | 1,980 | 1,982 | 1,944 | 1,949 | -23 | -1.2% | 174,300 |
2020/08/06 | 1,955 | 1,981 | 1,946 | 1,972 | -6 | -0.3% | 179,900 |
2020/08/05 | 1,975 | 1,983 | 1,943 | 1,978 | -15 | -0.8% | 206,200 |
2020/08/04 | 2,000 | 2,042 | 1,928 | 1,993 | +18 | +0.9% | 385,800 |
2020/08/03 | 1,962 | 2,030 | 1,940 | 1,975 | +52 | +2.7% | 300,400 |
2020/07/31 | 1,972 | 1,975 | 1,916 | 1,923 | -67 | -3.4% | 303,500 |
2020/07/30 | 1,988 | 2,001 | 1,979 | 1,990 | +1 | +0.1% | 154,300 |
2020/07/29 | 2,002 | 2,009 | 1,982 | 1,989 | ±0 | ±0% | 220,200 |
2020/07/28 | 1,996 | 2,004 | 1,984 | 1,989 | -21 | -1% | 218,200 |
2020/07/27 | 1,970 | 2,010 | 1,969 | 2,010 | +14 | +0.7% | 180,200 |
1101~
1150
件表示中 / 3674件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 136,500円 | +3.2% | +4.5% | 3.81% | 15.68倍 | 0.60倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
持田薬 | 290,300円 | +3.0% | +27.5% | 2.76% | 18.38倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
サンバイオ | 138,800円 | - | - | 0.00% | - | 64.29倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
栄研化 | 201,200円 | +0.4% | -8.4% | 2.63% | 25.83倍 | 1.46倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ジーエヌアイ | 149,000円 | +21.7% | +999.9% | 0.00% | 6.20倍 | 2.05倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム